3,6-Disinapoyl sucrose

CAS No. 139891-98-8

3,6-Disinapoyl sucrose( —— )

Catalog No. M17996 CAS No. 139891-98-8

3, 6'-Disinapoyl sucrose shows the neuroprotective effect and antidepressive activity in rats.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
5MG 56 In Stock
10MG 79 In Stock
25MG 128 In Stock
50MG 184 In Stock
100MG 272 In Stock
200MG 403 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,6-Disinapoyl sucrose
  • Note
    Research use only, not for human use.
  • Brief Description
    3, 6'-Disinapoyl sucrose shows the neuroprotective effect and antidepressive activity in rats.
  • Description
    3, 6'-Disinapoyl sucrose shows the neuroprotective effect and antidepressive activity in rats.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    NOS
  • Recptor
    Bcl-2| CREB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    139891-98-8
  • Formula Weight
    754.68
  • Molecular Formula
    C34H42O19
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (66.25 mM)
  • SMILES
    COc1cc(/C=C/C(=O)C([C@H]2OC(OC3(CO)O[C@@H]([C@H]([C@@H]3O)O)CO)[C@@H]([C@]([C@@H]2O)(O)C(=O)/C=C/c2cc(OC)c(c(c2)OC)O)O)O)cc(c1O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hu Y, et al. J Mol Neurosci. 2014 Aug;53(4):600-7.
molnova catalog
related products
  • EX-A5758

    EX-A5758 is a novel putative small molecule nNOS-NOS1AP inhibitor, suppressing inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.

  • IC-87201

    A small molecule inhibitor of PSD-95/nNOS interaction with IC50 of 31 uM.

  • ZL-006

    ZL-006 (ZL 006, ZL006) is a brain penetrant small molecule inhibitor of PSD-95/nNOS interaction that prevents glutamate-induced excitotoxicity and cerebral ischemic damage in vivo.